FDA Approves New Drug for Wilson's Disease

Trientine tetrahydrochloride (Cuvrior) is approved to treat adults with stable Wilson's disease who are decoppered and tolerant to penicillamine.

Related Keywords

New Haven ,Connecticut ,United States ,Yale University ,Michael Schilsky ,Maryl Graper ,Drug Administration ,Wilson Disease Association ,Wilson Disease ,Wilsons Disease ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Liver ,Brain ,Medical Literature ,Books ,Textbooks ,Ournals ,Clinical Research ,Clinical Trials ,Linical Studies ,Europe ,European ,